Warning letter
2-2-0 Laboratories: warning letter of Dec 27, 2001
FDA warning letter UCM178559 · Los Angeles District Office
Key facts
| Reference number | UCM178559 |
|---|---|
| Company | 2-2-0 Laboratories |
| Subject | Current Good Manufacturing Practices for Finished Pharmaceuticals/Adulterated |
| Issue date | Dec 27, 2001 |
| Posted date | Dec 27, 2001 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 211 |
| Country | 3 |
| Inspection city | Riverside |
| Inspection ZIP | 92507-3306 |
| Inspection start date | Dec 5, 2001 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- VAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: